Review describes how cost and disease burden of endocrine-disrupting chemicals (EDCs) can be reduced by policy actions informed by science; recommended solutions include updating testing to account for mixture, cumulative exposure, effects occurring later life; second review summarizes studies linking EDC exposure with immunological and metabolic impacts during pregnancy
EFSA: Scientific Opinion on the impact of NMDR on risk assessment
European Food Safety Authority (EFSA) publishes opinion on the impact of non-monotonic dose responses (NMDRs) on human health risk assessment; if NMDR may be present, suggests further testing at the low end of the dose-response curve; recommends developing internationally agreed guidance and harmonized frameworks for ‘identifying and addressing’ NMDRs during risk assessments
First episode of the ‘Unwrapping Food Packaging’ video blog published
Food Packaging Forum launches new video blog explaining key topics within the field of food packaging and health; host Jane Muncke introduces viewers in the first episode to fundamentals of chemical migration, low dose exposures, and chemical mixtures
Combined evidence supports low-dose effects of BPA
Scientists integrate and interpret data from 8 of the 14 academic studies completed under the CLARITY-BPA project; link bisphenol A (BPA) exposure to impacts across multiple organs including brain, heart, prostate, mammary gland, ovaries; strengthen confidence in low-dose effects of BPA; co-authors to present results in webinar on July 21, 2020
New infographics on EDCs
Health and Environment Alliance releases infographics on endocrine disrupting chemicals, focuses on the need to accommodate low dose effects and science advances into risk assessment
FPF Workshop 2018: Improving chemical safety by new science
Presentations at Food Packaging Forum 2018 workshop cover predictive toxicology, computational methodologies, green chemistry
CLARITY-BPA webinars: Key messages
Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects
Opinion: FDA ‘rushing to judgement’ on BPA
Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards
Webinar on CLARITY-BPA core study
U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open
Webinar on CLARITY-BPA academic studies
Carnegie Mellon University holds webinar on independent academic studies on bisphenol A within CLARITY-BPA program, September 12, 2018; registration now open